In order to validate the expression of GPC6 and TMEM132D in early stage ovarian cancer, we measured by qPCR their mRNA levels in tumor samples from 38 stage I-II ovarian cancer patients (Figures 1(b) and 2(b), resp). The gene discussed is GPC6; the disease is ovarian carcinoma.